Boston Globe: 'Knock out the middlemen' is a campaign promise Donald Trump should keep
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Hosted on MSN20h
We're 60 Weeks Into the Weight Loss Drug Revolution. Now What?
She’s racing to a run-through for a 14-course tasting menu she will barely nibble at as she raves about her weight loss on ...
STAT5h
Pharmalittle: We’re reading about a Super Bowl ad for compounded obesity drugs, a PEPFAR waiver, and more
A Super Bowl ad for weight loss medications from telehealth company Hims & Hers is optimized to engage and infuriate ...
What’s Trump Done on Prescription Drug Prices So Far – and What Might Be Next?
Early moves by the president raise questions about what direction his second-term policy on drug costs will take.
Medscape2h
GLP-1 for Complex Cases: Breakthrough Therapies That Transform Patient Care
Unlock the potential of GLP-1 therapies! Join experts to explore cutting-edge strategies for managing cardiovascular & ...
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives $53.81 Average Target Price from Analysts
Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eighteen research firms that are currently covering the company ...
Sinusitis Treatment Market Set To Reach US$ 3.5 Bn By 2031, Driven By Rising Cases And Advanced Treatment Options | Transparency Market Research
The growing demand for fast and effective sinusitis treatments is expected to drive further innovations in pharmaceuticals and medical devices. Increasing awareness, advancements in drug formulations ...